Tatjana Traub-Weidinger, Javier Arbizu, Henryk Barthel, Ronald Boellaard, Lise Borgwardt, Matthias Brendel, Diego Cecchin, Francine Chassoux, Francesco Fraioli, Valentina Garibotto, Eric Guedj, Alexander Hammers, Ian Law, Silvia Morbelli, Nelleke Tolboom, Donatienne Van Weehaeghe, Antoine Verger, Wim Van Paesschen, Tim J von Oertzen, Pietro Zucchetta, Franck Semah
Epilepsy is one of the most frequent neurological conditions with an estimated prevalence of more than 50 million people worldwide and an annual incidence of two million. Although pharmacotherapy with anti-seizure medication (ASM) is the treatment of choice, ~30% of patients with epilepsy do not respond to ASM and become drug resistant. Focal epilepsy is the most frequent form of epilepsy. In patients with drug-resistant focal epilepsy, epilepsy surgery is a treatment option depending on the localisation of the seizure focus for seizure relief or seizure freedom with consecutive improvement in quality of life...
February 23, 2024: European Journal of Nuclear Medicine and Molecular Imaging